Dr. Brian Keith Gamble , MD
General Practice • Los Angeles, CA
4300 Crenshaw Blvd
Los Angeles, CA 900084902
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 31, 2006; this date does not establish years in practice.
-
Published CMS data list 9,300 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 1,605 service units.
- 96132 — Evaluation of neuropsychological test, first hour: 998 service units.
- 96138 — Administration of psychological or neuropsychological test by technician: 995 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 29 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 9,600 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Amlodipine Besylate — 550 prescription fills, including refills.
- Atorvastatin Calcium — 539 prescription fills, including refills.
- Gabapentin — 353 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 164 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: 897. Middle half: 160 to 4,894.
More Medicare Part B services than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: 485. Middle half: 154 to 2,031.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,522 in 2020 to 9,300 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4300 Crenshaw Blvd
Los Angeles, CA 900084902
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Meharry Medical College School Of Medicine
1997
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
571 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $663,503 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $508,809 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
13,953 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$933,924 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $538.55 across 24 records.
By nature of payment
- Food and Beverage: $538.55 across 24 records.
Reporting-company totals (3 largest of 5)
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $279.32 across 14 records.
- Teva Pharmaceuticals USA, Inc.: $82.42 across 3 records.
- Xeris Pharmaceuticals, Inc.: $60.05 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
29 years (graduated 1997)
CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Los Angeles and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: 897. Middle half: 160 to 4,894.
More Medicare Part B services than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: 485. Middle half: 154 to 2,031.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: $84,340. Middle half: $14,329 to $427,622.
A higher Medicare-allowed amount than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $45,658. Middle half: $14,895 to $165,622.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: $59,034. Middle half: $10,306 to $334,098.
A higher Medicare payment amount than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $32,130. Middle half: $11,289 to $132,947.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under General Practice in Los Angeles, CA (2024, 73 clinicians with data). Median for this group: 911. Middle half: 99 to 3,151.
More Part D prescriptions than 90% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: 755. Middle half: 125 to 3,708.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under General Practice in Los Angeles, CA (2024, 73 clinicians with data). Median for this group: $35,867. Middle half: $1,749 to $228,354.
A higher Part D drug cost than 90% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: $49,322. Middle half: $2,066 to $279,323.
169 active clinicians are listed under General Practice with a practice address in Los Angeles, CA (1,964 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Los Angeles
9.5% of these 169 clinicians have the CMS telehealth indicator.
24.3% of these 169 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 43% from 6,522 in 2020 to 9,300 in 2024.
- 2020: 6,522
- 2021: 5,310
- 2022: 5,984
- 2023: 7,037
- 2024: 9,300
-
Medicare-allowed amount
Medicare-allowed amount increased 58% from $419,045 in 2020 to $663,503 in 2024.
- 2020: $419,045
- 2021: $390,210
- 2022: $519,814
- 2023: $548,531
- 2024: $663,503
-
Paid by Medicare
Paid by Medicare increased 57% from $323,909 in 2020 to $508,809 in 2024.
- 2020: $323,909
- 2021: $302,069
- 2022: $405,342
- 2023: $424,748
- 2024: $508,809
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 4979% from 189 in 2020 to 9,600 in 2024.
- 2020: 189
- 2021: 382
- 2022: 3,103
- 2023: 5,165
- 2024: 9,600
-
30-day fills
30-day fills increased 5179% from 264 in 2020 to 13,953 in 2024.
- 2020: 264
- 2021: 620
- 2022: 5,748
- 2023: 8,748
- 2024: 13,953
-
Part D drug cost
Part D drug cost increased 10583% from $8,742 in 2020 to $933,924 in 2024.
- 2020: $8,742
- 2021: $6,840
- 2022: $272,683
- 2023: $529,610
- 2024: $933,924
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $221.79 in 2021 to $538.55 in 2025.
- 2021: $221.79
- 2022: $241.90
- 2023: $138.60
- 2024: $195.48
- 2025: $538.55
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 24 records totaling $538.55.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $33.24 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $32.39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $32.32 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $30.70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $30.69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $30.30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $30.29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $28.95 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $28.93 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $28.08 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $27.36 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $26.70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $25.40 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $25.02 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $21.72 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $21.13 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $17.20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $12.50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $11.86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $10.91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $10.33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $10.15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $9.94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $2.44 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,605 | 456 | $110.00 | $91.52 |
|
96132
Evaluation of neuropsychological test, first hour
|
998 | 321 | $200.00 | $126.33 |
|
96138
Administration of psychological or neuropsychological test by technician, first 30 minutes
|
995 | 321 | $100.00 | $37.15 |
|
36415
Insertion of needle into vein for collection of blood sample
|
632 | 483 | $11.89 | $7.95 |
|
94375
Test to measure rate of airflow
|
593 | 452 | $60.00 | $40.71 |
|
94618
Test for exercise-induced lung stress
|
593 | 452 | $100.00 | $34.30 |
|
94200
Test to measure largest amount of air breathed in an out
|
592 | 451 | $50.00 | $15.79 |
|
94727
Test to determine lung volumes using gas dilution or washout
|
592 | 452 | $70.00 | $47.01 |
|
94729
Test to examine how well the lungs exchange gases
|
572 | 445 | $100.00 | $60.37 |
|
76872
Ultrasound scan of pelvic region through rectum
|
401 | 306 | $180.00 | $147.16 |
|
71046
X-ray of chest, 2 views
|
389 | 319 | $80.00 | $35.35 |
|
93975
Complete ultrasound of abdomen and pelvis artery and vein blood flow
|
225 | 189 | $320.00 | $279.65 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
198 | 198 | $130.00 | $112.95 |
|
76700
Complete ultrasound scan of abdomen
|
188 | 166 | $200.00 | $121.68 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
125 | 59 | $220.00 | $92.41 |
|
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
|
108 | 20 | $100.00 | $39.21 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
96 | 25 | $120.00 | $49.76 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
66 | 64 | $30.00 | $14.52 |
|
99483
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes
|
58 | 56 | $420.00 | $275.07 |
|
99454
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
|
49 | 15 | $150.00 | $51.13 |
|
G0180
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
|
48 | 39 | $120.00 | $55.52 |
|
93040
Electrocardiogram (ecg) 1 to 3 leads with review by physician
|
42 | 41 | $20.00 | $13.19 |
|
76775
Limited ultrasound scan behind abdominal cavity
|
40 | 33 | $200.00 | $61.57 |
|
72100
X-ray of lower and sacral spine, 2-3 views
|
20 | 20 | $180.00 | $42.22 |
|
G0179
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a
|
18 | 12 | $80.00 | $46.48 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 550 | 30,666 | $2,328.16 | 188 |
| Atorvastatin Calcium | Atorvastatin Calcium | 539 | 27,505 | $3,619.96 | 181 |
| Gabapentin | Gabapentin | 353 | 13,133 | $4,154.23 | 122 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 346 | 14,237 | $12,678.64 | 158 |
| Metformin Hcl | Metformin Hcl | 338 | 16,440 | $2,240.33 | 124 |
| Omeprazole | Omeprazole | 271 | 13,195 | $2,305.45 | 98 |
| Losartan Potassium | Losartan Potassium | 266 | 13,680 | $2,017.75 | 89 |
| Ibuprofen | Ibuprofen | 263 | 6,981 | $1,682.46 | 95 |
| Tamsulosin Hcl | Tamsulosin Hcl | 260 | 11,761 | $2,484.92 | 103 |
| Lisinopril | Lisinopril | 233 | 13,211 | $953.77 | 83 |
| Furosemide | Furosemide | 221 | 9,280 | $799.60 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 207 | 13,419 | $340.67 | 77 |
| Quetiapine Fumarate | Quetiapine Fumarate | 158 | 6,699 | $2,537.10 | 44 |
| Carvedilol | Carvedilol | 149 | 5,488 | $1,385.85 | 39 |
| Trazodone Hcl | Trazodone Hcl | 142 | 5,435 | $1,420.43 | 40 |
| Levothyroxine Sodium | Levothyroxine Sodium | 135 | 6,310 | $1,553.26 | 46 |
| Glipizide | Glipizide | 125 | 7,608 | $584.03 | 45 |
| Alprazolam | Alprazolam | 119 | 3,510 | $858.10 | 23 |
| Sertraline Hcl | Sertraline Hcl | 105 | 3,780 | $785.45 | 33 |
| Pantoprazole Sodium | Pantoprazole Sodium | 97 | 4,710 | $1,109.50 | 35 |
| Metoprolol Succinate | Metoprolol Succinate | 91 | 4,200 | $1,025.06 | 32 |
| Diclofenac Sodium | Diclofenac Sodium | 90 | 2,163 | $1,144.71 | 33 |
| Mirtazapine | Mirtazapine | 89 | 3,030 | $984.85 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 80 | 2,725 | $985.09 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 78 | 4,127 | $316.06 | 27 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-09-25NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 2085R0202X
A radiologist who utilizes x-ray, radionuclides, ultrasound and electromagnetic radiation to diagnose and treat disease.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Surgery
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4300 CRENSHAW BLVD, LOS ANGELES, CA 900084902 (Tel: 3232981668)
Registered at 1689 E JEFFERSON AVE, POMONA, CA 917674548 (Tel: 6616449348)
General Practice (license number reported to NPPES: CA A76121)
NPI status registered as active in NPPES database
Registered at 10701 RIVERSIDE DR, SUITE 16, TOLUCA LAKE, CA 916022384 (Tel: 8189851221)
Registered at 10701 RIVERSIDE DR, 16, TOLUCA LAKE, CA 916022384 (Tel: 8189851221)
Recorded as BRIAN GAMBLE, M.D.
Nuclear Medicine (license number reported to NPPES: CA A76121)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Los Angeles
- Dr. Vital Hinojosa, MD
- Dr. Cesar Velez, MD
- Dr. Samir Shahin, MD
- Dr. Shehan Thangaratnam, MD
- Dr. Vahe Azarian, MD
- Dr. Gregory Smookler, MD
Mailing Address
1689 E Jefferson Ave
Pomona, CA 917674548
Phone: 6616449348